Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | potassium voltage-gated channel, shaker-related subfamily, member 3 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | shaker cognate | potassium voltage-gated channel, shaker-related subfamily, member 3 | 575 aa | 465 aa | 34.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | putative regulatory protein | 0.0081 | 0 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0549 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0534 | 0.9678 | 1 |
Schistosoma mansoni | single-minded | 0.011 | 0.0611 | 0.041 |
Brugia malayi | hypoxia-induced factor 1 | 0.034 | 0.5536 | 0.5536 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0096 | 0.0304 | 0.0304 |
Loa Loa (eye worm) | hypothetical protein | 0.0369 | 0.6147 | 0.6233 |
Echinococcus multilocularis | potassium voltage gated channel subfamily A | 0.0099 | 0.0381 | 0.0381 |
Schistosoma mansoni | hypothetical protein | 0.0446 | 0.7801 | 1 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.034 | 0.5536 | 0.5581 |
Echinococcus granulosus | sodium and chloride dependent glycine | 0.0096 | 0.0304 | 0.0304 |
Echinococcus granulosus | sodium and chloride dependent glycine | 0.0096 | 0.0304 | 0.0304 |
Echinococcus granulosus | potassium voltage gated channel protein | 0.0104 | 0.0478 | 0.0478 |
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 0.0478 | 0.0186 |
Echinococcus multilocularis | sodium and chloride dependent glycine | 0.0096 | 0.0304 | 0.0304 |
Brugia malayi | hypothetical protein | 0.0369 | 0.6147 | 0.6147 |
Onchocerca volvulus | 0.0431 | 0.7479 | 1 | |
Echinococcus granulosus | jun protein | 0.0549 | 1 | 1 |
Brugia malayi | Voltage-gated potassium channel, Shaker-family (KCNA, Kv1-like) alpha-subunit | 0.0104 | 0.0478 | 0.0478 |
Schistosoma mansoni | jun-related protein | 0.0446 | 0.7801 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0104 | 0.0478 | 0.0233 |
Echinococcus multilocularis | potassium voltage gated channel protein | 0.0104 | 0.0478 | 0.0478 |
Echinococcus multilocularis | sodium and chloride dependent glycine | 0.0096 | 0.0304 | 0.0304 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0549 | 1 | 1 |
Echinococcus granulosus | potassium voltage gated channel subfamily A | 0.0104 | 0.0478 | 0.0478 |
Brugia malayi | PAS domain containing protein | 0.011 | 0.0611 | 0.0611 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.011 | 0.0611 | 0.041 |
Echinococcus multilocularis | jun protein | 0.0549 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0431 | 0.7479 | 0.7479 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0104 | 0.0478 | 0.0233 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 5 nM | Inhibition of DiTc binding to Kv1.3 channel in human brain membranes | ChEMBL. | 12643934 |
IC50 (binding) | = 5 nM | Inhibition of DiTc binding to Kv1.3 channel in human brain membranes | ChEMBL. | 12643934 |
IC50 (binding) | = 33 nM | Inhibition of DiTc binding to Kv1.x channel in human brain membranes | ChEMBL. | 12643934 |
IC50 (functional) | = 58 nM | Inhibition of [86Rb+] efflux from CHO cells stably transfected with Kv1.3 channel | ChEMBL. | 12643934 |
IC50 (functional) | = 58 nM | Inhibition of [86Rb+] efflux from CHO cells stably transfected with Kv1.3 channel | ChEMBL. | 12643934 |
IC50 (functional) | = 195 nM | Inhibition of T-cell proliferation was determined by a human T-cell assay | ChEMBL. | 12643934 |
IC50 (functional) | = 195 nM | Inhibition of T-cell proliferation was determined by a human T-cell assay | ChEMBL. | 12643934 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.